Efficacy of dupilumab for controlling severe atopic dermatitis with dominant-negative CARD11 variant.
Estelle CharvetE BourratG HickmanJ DonadieuC Bellanné-ChantelotMarie JachietJ-D BouazizMartine BagotC CassiusPublished in: Clinical and experimental dermatology (2021)
Keyphrases